Homocysteine and risk in end-stage renal disease: a matter of context.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16408106.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Like blood pressure and cholesterol, homocysteine shows a paradoxical inverse relationship with cardiovascular complications in end-stage renal disease (ESRD). A paper by Ducloux et al. in this issue adds perhaps decisive evidence on malnutrition-hypoalbuminemia as the main factor explaining the counterintuitive association between homocysteine and clinical outcome reported in previous studies.
Medical subject headings
- Homocysteine
- Kidney Failure, Chronic